|| Print ||
|Archives - April 2008|
|Tuesday, April 01, 2008|
Tiny, stainless steel lattice tubes have been propping coronary arteries open since the 1980s, but never without triggering reactions in some patients that are worse than untreated heart disease. In 2001, scientists began coating stents with drugs to help prevent heart attack-inducing blood clots. But 30,000 out of the 6 million patients worldwide who receive them still die. “Metal is inherently not biocompatible,” says Dr. Kenton Gregory, director of Oregon Medical Laser Center at Providence St. Vincent Medical Center in Portland. More than a decade ago, Gregory decided he needed to go back to nature if stent technology was to move forward. Gregory, whose work at the center has received 22 patents and $25 million in grants, developed a coating modeled after the artery wall’s own lining: a protein called elastin. As the name suggests, the protein stretches without breaking and molds well to any object it coats, even metal tubes 1.5 mm in diameter and 12 mm in length. Most importantly, the body won’t reject it. Gregory and his team at OMLC completed tests on domestic pigs last fall with “extremely successful” results and plan to start human trials in Brazil later this year. Once the design gets FDA approval — Gregory expects within two years — he’ll begin marketing the new device in hopes that this “metal, human-protein hybrid” will succeed where lesser stents have failed. Lives saved by listening to nature. EVAN CAEL
Wednesday, July 09, 2014
BY LINDA BAKER | OB EDITOR
Scott Kveton, the CEO of Urban Airship is taking a leave of absence from the company. As the story continues to unfold, here’s our perspective on a few of the key players.
Thursday, July 24, 2014
BY CLIFF HOCKLEY | OB GUEST CONTRIBUTOR
With the increasing retirements of Baby Boomers, a massive real estate shift has created a significant increase in demand for NNN properties. The result? Increased demand has triggered higher prices and lower yields.
Thursday, June 26, 2014
BY ERIC FRUTS | OB BLOGGER
Last year, the housing market in Oregon—and the U.S. as a whole—was blasting off. The Case-Shiller index of home prices ended the year 13% higher than at the beginning of the year. But, was last year a blip, or a trend?
Thursday, June 26, 2014
Monday, June 16, 2014
The Oregon economy could get a boost from a new trade agreement being negotiated between the U.S. and the European Union.
Monday, July 14, 2014
BY TERRY "STARBUCKER" ST. MARIE
I really didn’t know that much about angel investing, but I did know a lot about the entrepreneurial spirit.
Friday, June 27, 2014
BY JASON NORRIS | OB BLOGGER
Over the last several months we have seen a wave of cross-border acquisitions, primarily U.S.-based companies looking to purchase non-U.S.-based companies. There are a few reasons for this, but the main culprit is the U.S. corporate tax system. The United States has one of the highest corporate tax rates in the world.
|The Private 150: Bigger But Leaner|
|The Perfect Food|
|Taxis Uber Alles?|
|Powerlist: Staffing Firms|
|Zillow to acquire Trulia for $3.5B|
|Dollar Tree to buy Family Dollar|
|Facebook revenue surges 61%|
|Walmart unexpectedly fires CEO|
|GM profit declines 80%|
|Study: Dogs can feel jealousy|
|Boeing profit surges 52%|
Vigilant enters a New Year with a new president.
How George Fox has become one of Oregon's largest private universities.
Forest Grove sees growth in the burgeoning food and beverage scene.
Lane Powell Shareholder Susan K. Eggum has been elected as vice chair of programs and projects for the International Association of Defense Counsel’s (IADC’s) Employment Law Committee.
Geffen Mesher is saddened to announce the passing of long-time shareholder, Tom “Mike” Anderson, who died on July 10, 2014, from liver disease diagnosed after recent heart surgery. He was 55 years old.
Fifteen Lane Powell attorneys have been named 2014 “Oregon Super Lawyers,” and another five attorneys have been named as “Oregon Rising Stars” by Super Lawyers magazine.